All Posts By

Smartkarma Daily Briefs

Daily Brief Japan: Sekisui House, Kadokawa Dwango, Raccoon Holdings, Inc. and more

By | Daily Briefs, Japan

In today’s briefing:

  • Sep22 FTSE EPRA Nareit Index Rebalance – Big Impact on Sekisui House (1928 JP)
  • Kadokawa – Investments From Sony and Tencent
  • Raccoon: Maintaining COVID Momentum

Sep22 FTSE EPRA Nareit Index Rebalance – Big Impact on Sekisui House (1928 JP)

By Travis Lundy

  • Yesterday FTSE Russell announced two Asian additions to its FTSE EPRA Nareit Global Developed Index – Sekisui House (1928 JP) and Healthcare & Medical Investment Corporation (3455 JP)
  • Sekisui House is larger cap, and will see big dollars added. H&M IC is much smaller and will see less, but has had a huge run-up, outright and relative.
  • Trading impact will be significant on both tickers in terms of days of ADV.

Kadokawa – Investments From Sony and Tencent

By Mio Kato

  • Kadokawa announced yesterday that subsidiary From Software would conduct a third-party allocation of shares to Sony and Tencent. 
  • The allotment values From Software at about ¥120bn with Tencent acquiring 16.25% and Sony acquiring 14.09% of the company. 
  • This creates opportunities for both Sony and Tencent and likely puts Kadokawa on track to eventually be acquired though timing may be somewhat later than we had anticipated.

Raccoon: Maintaining COVID Momentum

By Oshadhi Kumarasiri

  • While its peers in Japanese e-commerce are losing momentum, Tokyo-listed B2B e-commerce company, Raccoon Holdings, Inc. (3031 JP) continues to march forward from the COVID elevated levels.
  • With the advertising cost no longer growing at the same rate as before, we expect around 60% upside to Raccoon’s FY+2 consensus OP of ¥1.6bn.
  • This would put Raccoon on 9.5x FY+2 OP with an OP CAGR of close to 50% and seems reasonably cheap in our opinion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: PC Partner, Hang Lung, Leapmotor, Alibaba (ADR), Bilibili, Onewo Space-Tech, China Communications Construction, Burning Rock Biotech, Fosun International, Beijing Continent Pharmaceuticals and more

By | China, Daily Briefs

In today’s briefing:

  • PC Partner: Strong 1H22 but High Uncertainty into 2H22. Downside Supported by Cash and Dividend.
  • Hang Lung Group Chips Away At Holding In Hang Lung Props
  • Leapmotor Pre-IPO – Thoughts on Valuation
  • Alibaba, Longfor Group, Country Garden, New World Development
  • Bilibili (9626 HK): 2Q22 Preview, Still Grew Rapidly, Will Reduce Loss
  • Onewo IPO: The Bull Case
  • China Comm Const (1800 HK): Key Takeaways from Post-1H22 Call
  • Burning Rock Biotech (BNR US): Despite Q2 Results Missing Consensus Management Reiterated Guidance
  • Fosun International – Earnings Flash – H1 FY 2022 Results – Lucror Analytics
  • Pre-IPO Beijing Continent Pharmaceuticals – The Orphan Drug Pioneer Needs to Expand Overseas

PC Partner: Strong 1H22 but High Uncertainty into 2H22. Downside Supported by Cash and Dividend.

By Nicolas Van Broekhoven

  • Pc Partner reported a strong set of 1H22 results last week and held a conf call with investors this week. Importantly, management sees no impact by US/China Nvidia AI situation.
  • 3Q22 results will be weak as old inventory is being discounted in front of the launch of RTX 40 by NVIDIA Corp (NVDA US) in early 4Q22.
  • Stock is unlikely to rally before more clarity on inventory situation improvement, but well supported by net cash (5.4 HKD) and high interim dividend (11.4%). 

Hang Lung Group Chips Away At Holding In Hang Lung Props

By David Blennerhassett

  • Hang Lung (10 HK) recently announced it had acquired 1.3% in Hang Lung Properties (101 HK) over a one-year period, increasing its holding to 59.5%.
  • HLG currently trades at a 62% discount to NAV, a level last seen around the Covid lows in May 2020.
  • HLG is the most basic of Holdco structures – there is almost a 100% overlap in the stub ops with HLP’s property investments. 

Leapmotor Pre-IPO – Thoughts on Valuation

By Sumeet Singh

  • Leapmotor (LM) aims to raise around US$1.5bn in its Hong Kong IPO. LM is a smart EV company based in China, founded in 2015.
  • As of end Jun 22, it had delivered a total of 104,829 cars with most of its sales coming from its mini units, T03.
  • In our previous note, we spoke about the company’s past performance,  PHIP updates and undertook a peer comparison. In this note, we will talk about valuations.

Alibaba, Longfor Group, Country Garden, New World Development

By Untying The Gordian Knot

  • Two big headlines drove the short squeeze, helped by the record level of short selling as a percentage of total volume in recent months.
  • The recovery remains a low volume rally and short turnover as share continues to be high.
  • Most of the short selling remains in Index ETF and very large-cap stocks.

Bilibili (9626 HK): 2Q22 Preview, Still Grew Rapidly, Will Reduce Loss

By Ming Lu

  • In 2Q22, we believe revenue will grow fast, especially for value added service and advertising.
  • We believe operating loss will shrink, but far from making profit.
  • We believe the stock has an upside of 18% for the end of 2023.

Onewo IPO: The Bull Case

By Arun George

  • Onewo Space-Tech (ONEWO HK), China Vanke (000002 CH)’s property management unit, has begun pre-marketing a US$2.0 billion HKEx IPO.
  • Onewo ranked first in China’s property management services market as measured by revenue from basic property management services, with a market share of 4.28% in 2021.
  • The key elements of the bull case rest on the solid financial health of the parent, strong growth, growth runway from undelivered GFA, share gains, renewal rates and cash generation.

China Comm Const (1800 HK): Key Takeaways from Post-1H22 Call

By Osbert Tang, CFA

  • China Communications Construction (1800 HK) should see positive new contract momentum in 2H22. We also expect softening in cost pressure to bring about better margin. 
  • It is actively looking to recycle and realise the value of its assets and good progress are expected in 2H22. Such moves will narrow the currently deeply discounted 0.18x P/B. 
  • With order backlog amounting to 4.6x of annualised 1H22 revenue, earnings prospects are well secured, making its FY22F PER of 2.6x and FY23F of 2.3x very cheap.

Burning Rock Biotech (BNR US): Despite Q2 Results Missing Consensus Management Reiterated Guidance

By Tina Banerjee

  • Burning Rock Biotech (BNR US) has announced Q2 results. Despite the negative impact from COVID-related restrictions in China, revenue increased 3% y/y to RMB130.8 million, driven by pharma R&D service.
  • Gross margin deteriorated due to unfavorable revenue mix and inventory write down. Even upon this, operating expenses grew 19%, thereby widening net loss to RMB262.1 million.
  • Encouraged by ongoing business volume recovery, management has reiterated full-year 2022 revenue guidance of approximately RMB620 million, indicating H2 2022 revenue of RMB354 million, which represents 29% y/y growth.    

Fosun International – Earnings Flash – H1 FY 2022 Results – Lucror Analytics

By Trung Nguyen

Fosun International’s H1/22 results appear to be reasonable, with higher revenue but lower earnings. The reported credit metrics are not very representative of the credit profile in our view, given the company’s investment holding nature. Thus, it is difficult to assess Fosun’s credit health. However, we take some comfort from the rate of divestments, which is outpacing the rate of investments. Reported liquidity on a consolidated basis seems adequate. That said, we have no visibility on liquidity at the holdco.

Still, we highlight that Fosun has major assets to be sold, especially those without ample synergies. The company has accelerated its asset sale process since 2021. However, it cannot name the assets currently, as details of the transactions are still confidential. Moreover, Fosun does not wish to affect the morale of employees at these assets. The asset disposals are focused on non-core assets, which are typically not listed.


Pre-IPO Beijing Continent Pharmaceuticals – The Orphan Drug Pioneer Needs to Expand Overseas

By Xinyao (Criss) Wang

  • With favorable policies and improved intellectual property protection, investors’ attitude towards rare diseases in China has changed significantly and become more interested in this field.
  • Since no new candidates would be commercialized until 2024, Beijing Continent Pharmaceuticals (CPH HK) could face increasing competition and financial pressure. The breakthrough point is to develop overseas markets.
  • In terms of valuation, Continent is better than CANbridge Pharmaceuticals (1228 HK), so it is expected to have higher valuation than CANbridge after listing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Utilities: Azure Power Global Ltd and more

By | Daily Briefs, Utilities Sector

In today’s briefing:

  • Morning Views Asia: ABM Investama, Azure Power Global Ltd

Morning Views Asia: ABM Investama, Azure Power Global Ltd

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Energy/Materials: Fosun International, Prima Marine PCL, Synthomer PLC and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Fosun International – Earnings Flash – H1 FY 2022 Results – Lucror Analytics
  • PRM : Excited Fleet Expansion Plan
  • Europe will be fine

Fosun International – Earnings Flash – H1 FY 2022 Results – Lucror Analytics

By Trung Nguyen

Fosun International’s H1/22 results appear to be reasonable, with higher revenue but lower earnings. The reported credit metrics are not very representative of the credit profile in our view, given the company’s investment holding nature. Thus, it is difficult to assess Fosun’s credit health. However, we take some comfort from the rate of divestments, which is outpacing the rate of investments. Reported liquidity on a consolidated basis seems adequate. That said, we have no visibility on liquidity at the holdco.

Still, we highlight that Fosun has major assets to be sold, especially those without ample synergies. The company has accelerated its asset sale process since 2021. However, it cannot name the assets currently, as details of the transactions are still confidential. Moreover, Fosun does not wish to affect the morale of employees at these assets. The asset disposals are focused on non-core assets, which are typically not listed.


PRM : Excited Fleet Expansion Plan

By Pi Research

  • Maintain HOLD recommendation for PRM but raised target price to Bt6.60 (Previous TP: Bt6.30) after revised earnings up by 16-25% in 2022-23E. We are positive toward 2H22 fleet expansion plan
  • 2Q22 core profit dropped QoQ and YoY Report 2Q22 net profit at Bt199m. Excluding FX item,core earnings would be at Bt262m (-38%YoY -2%QoQ) YoY drop was due to high base 
  • Core revenue hit all-time high at Bt1.7bn along with fleet expansion(59 vessels as of 2Q22)and an increase in transportation volume for domestic trading business (45% of total revenue in 2Q22)

Europe will be fine

By Turtles all the way down

  • Lately I have seen a lot of doomporn on Twitter about Europe. A lot of people seem to almost be excited about the energy predicament Europe is in.
  • So I thought I would write some anti-doom porn. And in doing so I actually became a bit more pessimistic LOL. At least for the next year or two.
  • Since there is no denying that the EU is in a bad spot as it imported 150 billion m3 of gas from Russia.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Health Care: Burning Rock Biotech, Beijing Continent Pharmaceuticals, Abbvie Inc, Medici Vietnam and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Burning Rock Biotech (BNR US): Despite Q2 Results Missing Consensus Management Reiterated Guidance
  • Pre-IPO Beijing Continent Pharmaceuticals – The Orphan Drug Pioneer Needs to Expand Overseas
  • AbbVie Inc: Agreement With Cugene & Other Developments
  • Jungle Ventures Leads Vietnamese Insurtech Startup Medici’s Series A Round

Burning Rock Biotech (BNR US): Despite Q2 Results Missing Consensus Management Reiterated Guidance

By Tina Banerjee

  • Burning Rock Biotech (BNR US) has announced Q2 results. Despite the negative impact from COVID-related restrictions in China, revenue increased 3% y/y to RMB130.8 million, driven by pharma R&D service.
  • Gross margin deteriorated due to unfavorable revenue mix and inventory write down. Even upon this, operating expenses grew 19%, thereby widening net loss to RMB262.1 million.
  • Encouraged by ongoing business volume recovery, management has reiterated full-year 2022 revenue guidance of approximately RMB620 million, indicating H2 2022 revenue of RMB354 million, which represents 29% y/y growth.    

Pre-IPO Beijing Continent Pharmaceuticals – The Orphan Drug Pioneer Needs to Expand Overseas

By Xinyao (Criss) Wang

  • With favorable policies and improved intellectual property protection, investors’ attitude towards rare diseases in China has changed significantly and become more interested in this field.
  • Since no new candidates would be commercialized until 2024, Beijing Continent Pharmaceuticals (CPH HK) could face increasing competition and financial pressure. The breakthrough point is to develop overseas markets.
  • In terms of valuation, Continent is better than CANbridge Pharmaceuticals (1228 HK), so it is expected to have higher valuation than CANbridge after listing.

AbbVie Inc: Agreement With Cugene & Other Developments

By Baptista Research

  • AbbVie has witnessed a strong correction over the past few months and its results have also not been the best.
  • The company’s revenues in the last result were below market expectations though it did deliver an earnings beat.
  • The silver lining for AbbVie has been the strong growth in double-digit operational sales from immunology, where Skyrizi exceeded the expectation of the company with its impressive market share gains in both PSA and psoriasis.

Jungle Ventures Leads Vietnamese Insurtech Startup Medici’s Series A Round

By e27

  • Iinsurance startup Medici claims it has hit double-digit m-o-m growth and has 35+ branches across almost 40 provinces.

  • Vietnamese healthtech and insurance startup Medici has received an undisclosed sum in a Series A round led by existing backer Jungle Ventures.
  • The company will use the money to improve its technology infrastructure to capture the tremendous growth opportunity of Vietnam’s insurance and healthcare market.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Comfortdelgro Corp, Bharat Electronics, Adani Enterprises, China Communications Construction, Sany Heavy Industry, United Airlines Holdings and more

By | Daily Briefs, Industrials

In today’s briefing:

  • STI Index Rebalance: Emperador IN, ComfortDelGro OUT
  • NIFTY NEXT50 Index Rebalance: Significant Impact for an Overlooked Index
  • NIFTY50 Index Rebalance: Adani Enterprises Replaces Shree Cement
  • China Comm Const (1800 HK): Key Takeaways from Post-1H22 Call
  • NIFTY Sep 2022 Rebal: Adani Enterprises and Adani Total Gas Are Top Positives
  • Sany Profit Falls 73.85% as Demand for Construction Gear Dries Up
  • United Airlines: Sustainable Aviation Fuel Update & Other Drivers

STI Index Rebalance: Emperador IN, ComfortDelGro OUT

By Brian Freitas



NIFTY50 Index Rebalance: Adani Enterprises Replaces Shree Cement

By Brian Freitas


China Comm Const (1800 HK): Key Takeaways from Post-1H22 Call

By Osbert Tang, CFA

  • China Communications Construction (1800 HK) should see positive new contract momentum in 2H22. We also expect softening in cost pressure to bring about better margin. 
  • It is actively looking to recycle and realise the value of its assets and good progress are expected in 2H22. Such moves will narrow the currently deeply discounted 0.18x P/B. 
  • With order backlog amounting to 4.6x of annualised 1H22 revenue, earnings prospects are well secured, making its FY22F PER of 2.6x and FY23F of 2.3x very cheap.

NIFTY Sep 2022 Rebal: Adani Enterprises and Adani Total Gas Are Top Positives

By Janaghan Jeyakumar, CFA

  • The September 2022 Rebalance results for the NIFTY 50, 100, and 500 Indices were announced after the close on 1st September 2022.
  • There will be one ADD/DEL for the NIFTY 50 Index and 6 ADDs/DELs for the NIFTY 100 Index, mostly in line with our expectations.
  • In this insight, we take a closer look at our expectations for index flows and potential trading ideas.

Sany Profit Falls 73.85% as Demand for Construction Gear Dries Up

By Caixin Global

  • Sany Heavy Industry, one of China’s largest construction machinery makers, reported a plunge in first-half profit as slower growth and Covid restrictions reduce demand for building equipment.
  • Revenue fell 40.9% to 39.7 billion yuan ($5.76 billion) for the first six months of 2022, the company said Tuesday. Net income plummeted 73.85% to 2.63 billion yuan.
  • Excavators are Sany’s core product. In the first half, the company’s excavator sales declined 35.6% year-on-year to 16.7 billion yuan

United Airlines: Sustainable Aviation Fuel Update & Other Drivers

By Baptista Research

  • United Airlines had a disappointing quarter despite seeing an unprecedented return of customers.
  • In this quarter, Cargo remained strong and premium leisure has been a bright spot as the domestic revenue growth of premium cabins outpaces the economy cabin.
  • We provide the United Airlines stock with a ‘Hold’ rating with a revised target price.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Consumer: Sekisui House, Kadokawa Dwango, Leapmotor, Raccoon Holdings, Inc., TBO Tek, Colgate Palmolive Co and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Sep22 FTSE EPRA Nareit Index Rebalance – Big Impact on Sekisui House (1928 JP)
  • Kadokawa – Investments From Sony and Tencent
  • Leapmotor Pre-IPO – Thoughts on Valuation
  • Raccoon: Maintaining COVID Momentum
  • TBO Tek Pre-IPO – Recovery Underway Post-COVID
  • Colgate-Palmolive: New Acquisitions For Supporting Pet Nutrition & Other Drivers

Sep22 FTSE EPRA Nareit Index Rebalance – Big Impact on Sekisui House (1928 JP)

By Travis Lundy

  • Yesterday FTSE Russell announced two Asian additions to its FTSE EPRA Nareit Global Developed Index – Sekisui House (1928 JP) and Healthcare & Medical Investment Corporation (3455 JP)
  • Sekisui House is larger cap, and will see big dollars added. H&M IC is much smaller and will see less, but has had a huge run-up, outright and relative.
  • Trading impact will be significant on both tickers in terms of days of ADV.

Kadokawa – Investments From Sony and Tencent

By Mio Kato

  • Kadokawa announced yesterday that subsidiary From Software would conduct a third-party allocation of shares to Sony and Tencent. 
  • The allotment values From Software at about ¥120bn with Tencent acquiring 16.25% and Sony acquiring 14.09% of the company. 
  • This creates opportunities for both Sony and Tencent and likely puts Kadokawa on track to eventually be acquired though timing may be somewhat later than we had anticipated.

Leapmotor Pre-IPO – Thoughts on Valuation

By Sumeet Singh

  • Leapmotor (LM) aims to raise around US$1.5bn in its Hong Kong IPO. LM is a smart EV company based in China, founded in 2015.
  • As of end Jun 22, it had delivered a total of 104,829 cars with most of its sales coming from its mini units, T03.
  • In our previous note, we spoke about the company’s past performance,  PHIP updates and undertook a peer comparison. In this note, we will talk about valuations.

Raccoon: Maintaining COVID Momentum

By Oshadhi Kumarasiri

  • While its peers in Japanese e-commerce are losing momentum, Tokyo-listed B2B e-commerce company, Raccoon Holdings, Inc. (3031 JP) continues to march forward from the COVID elevated levels.
  • With the advertising cost no longer growing at the same rate as before, we expect around 60% upside to Raccoon’s FY+2 consensus OP of ¥1.6bn.
  • This would put Raccoon on 9.5x FY+2 OP with an OP CAGR of close to 50% and seems reasonably cheap in our opinion.

TBO Tek Pre-IPO – Recovery Underway Post-COVID

By Ethan Aw

  • TBO Tek (0395045D IN) is looking to raise approximately US$285m in its upcoming India IPO.  
  • TBO Tek is a global travel distribution platform. Its two-sided technology platform serves companies involved in the travel industry such as hotels, airlines, travel agencies and travel management companies. 
  • The firm’s profitability recovery is underway post-COVID. However, the implied take rate of its largest revenue contributor (Hotel and Ancillary) appears to be declining despite the overall increase in GTV.

Colgate-Palmolive: New Acquisitions For Supporting Pet Nutrition & Other Drivers

By Baptista Research

  • Colgate-Palmolive had a splendid quarter and surged past Wall Street expectations on all counts by delivering growth over all of its categories as well as its divisions.
  • The company has built up its innovation capabilities to deliver more transformational innovation and breakthroughs that can drive both market share and category market.
  • Organic sales growth has been seen in four of its categories Home Care, Personal Care, Pet Nutrition, and Oral Care.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: PC Partner, Alibaba (ADR), Bilibili, CARRO, Intel Corp, Crowdstrike Holdings Inc, Glints, Jet Commerce, Ansys Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • PC Partner: Strong 1H22 but High Uncertainty into 2H22. Downside Supported by Cash and Dividend.
  • Alibaba, Longfor Group, Country Garden, New World Development
  • Bilibili (9626 HK): 2Q22 Preview, Still Grew Rapidly, Will Reduce Loss
  • Carro Sees Profitability, Doubles Revenue to $464m
  • Intel Vs. TSMC/UMC Long/Sort Monitor: Take-Aways from DB Conference & Fireside Chat
  • Crowdstrike FY2Q23: FY2Q23: Not Just Endpoint, Identity and SIEM Accelerating Too
  • Glints Bags $50m Series D Funding After Doubling Revenue and Gross Profits
  • Jet Commerce Raises US$60M for Brazil and Singapore Expansion, to Further Scale up in China
  • Ansys Inc: The New R2 2022 & Other Drivers

PC Partner: Strong 1H22 but High Uncertainty into 2H22. Downside Supported by Cash and Dividend.

By Nicolas Van Broekhoven

  • Pc Partner reported a strong set of 1H22 results last week and held a conf call with investors this week. Importantly, management sees no impact by US/China Nvidia AI situation.
  • 3Q22 results will be weak as old inventory is being discounted in front of the launch of RTX 40 by NVIDIA Corp (NVDA US) in early 4Q22.
  • Stock is unlikely to rally before more clarity on inventory situation improvement, but well supported by net cash (5.4 HKD) and high interim dividend (11.4%). 

Alibaba, Longfor Group, Country Garden, New World Development

By Untying The Gordian Knot

  • Two big headlines drove the short squeeze, helped by the record level of short selling as a percentage of total volume in recent months.
  • The recovery remains a low volume rally and short turnover as share continues to be high.
  • Most of the short selling remains in Index ETF and very large-cap stocks.

Bilibili (9626 HK): 2Q22 Preview, Still Grew Rapidly, Will Reduce Loss

By Ming Lu

  • In 2Q22, we believe revenue will grow fast, especially for value added service and advertising.
  • We believe operating loss will shrink, but far from making profit.
  • We believe the stock has an upside of 18% for the end of 2023.

Carro Sees Profitability, Doubles Revenue to $464m

By Tech in Asia

  • Singapore-based Carro more than doubled its revenue in its latest financial year, raking in more than S$650 million (US$464.2 million) in revenue.

  • The used-car platform, which also achieved profitability in FY 2021, said it is tracking at over US$930 million in run-rate revenue. It expects to see another 2x growth in revenue for FY 2023.
  • Aaron Tan, co-founder and CEO of Carro, attributed the firm’s profitability to its focus on online retailing and machine learning.

Intel Vs. TSMC/UMC Long/Sort Monitor: Take-Aways from DB Conference & Fireside Chat

By Vincent Fernando, CFA

  • On August 31st, Intel’s GM of Data Center & AI spoke at Deutsche Bank’s Technology Conference. On the same day, another executive spoke at Arete Research’s fireside chat.
  • Q2 and Q3E should be the bottom for the business, implying a rebound in Q4. Consensus estimates a similar trend; the latest comments are a confirmation of Q2 results guidance.
  • We see opportunities for positive news flow in September and Q3 results, as Intel could make key product announcements and guide for Q4 to be a turnaround.

Crowdstrike FY2Q23: FY2Q23: Not Just Endpoint, Identity and SIEM Accelerating Too

By Aaron Gabin

  • Crowdstrike continues to gobble up share, printing another strong beat and raise, with ARR now at $2B, the second fastest software company to hit that mark.
  • EBIT margins up 800bps YoY, TTM FCF Margins 30%…profitable growth at Scale.
  • 13x forward P/S for a unique software asset with long runways for 40%+ growth and multi-module driven margin expansion with a 15% pullback in the past week despite earnings.

Glints Bags $50m Series D Funding After Doubling Revenue and Gross Profits

By Tech in Asia

  • Glints, a Singapore-based careers platform, has raised US$50 million in a series D funding round co-led by DCM Ventures, Lavender Hill Capital, and Persol Holdings.
  • The deal pushed the firm’s total funding to date to more than US$80 million, making it the most funded startup in Southeast Asia’s talent recruitment space.
  • Glints connects companies to talent pools in Indonesia, Malaysia, Singapore, Vietnam, the Philippines, and Taiwan

Jet Commerce Raises US$60M for Brazil and Singapore Expansion, to Further Scale up in China

By e27

  • Jet Commerce launched a Live Commerce service through its newest business unit, Lumbalumba, last July and inaugurated its live streaming centre
  • Indonesia-based e-commerce enabler, Jet Commerce, has announced the completion of its Series B funding round of more than US$60 million (IDR 900 billion).
  • Jet Commerce will use the funds to upgrade infrastructure, recruit more professional local talent, improve research and technology development, and strengthen its ability in brand incubation.

Ansys Inc: The New R2 2022 & Other Drivers

By Baptista Research

  • This was an excellent quarter for Ansys, where the company managed to surpass Wall Street expectations in terms of revenues as well as earnings.
  • From the geographical perspective, the company viewed robust revenue growth from EMEA, the Americas, and the Asia Pacific.
  • Among key updates, TSMC certified the Power integrity software of Ansys for its NTE process and industry-leading N4P technologies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: Hang Lung, Warehouse REIT, Onewo Space-Tech, Siam Commercial Bank, Central China Real Estate, Ethereum, Square Inc, China SCE, CIFI Holdings and more

By | Daily Briefs, Financials

In today’s briefing:

  • Hang Lung Group Chips Away At Holding In Hang Lung Props
  • FTSE UK Sep 2022 Rebal: Warehouse REIT (WHR) Sees HUGE Impact
  • Onewo IPO: The Bull Case
  • SCBx – Positive Strategy Development
  • Central China – Earnings Flash – H1 FY 2022 Results – Lucror Analytics
  • Derivatives Dominate ETH Markets Ahead of Merge
  • Block Inc (formerly Square Inc): The New Square Stand & Other Drivers
  • China SCE – Earnings Flash – H1 FY 2022 Results – Lucror Analytics
  • CIFI Holdings – Earnings Flash – H1 FY 2022 Results – Lucror Analytics

Hang Lung Group Chips Away At Holding In Hang Lung Props

By David Blennerhassett

  • Hang Lung (10 HK) recently announced it had acquired 1.3% in Hang Lung Properties (101 HK) over a one-year period, increasing its holding to 59.5%.
  • HLG currently trades at a 62% discount to NAV, a level last seen around the Covid lows in May 2020.
  • HLG is the most basic of Holdco structures – there is almost a 100% overlap in the stub ops with HLP’s property investments. 

FTSE UK Sep 2022 Rebal: Warehouse REIT (WHR) Sees HUGE Impact

By Janaghan Jeyakumar, CFA

  • The index changes for the FTSE UK Indices for the September 2022 Rebalance were announced yesterday. There will be 3 changes for FTSE 100 and 8 changes for FTSE 250.
  • These index changes are mostly in line with our expectations in FTSE UK Quiddity Leaderboard Sep 2022: Avast, Meggitt, Brewin, and a Busy Rebalance Month
  • However, there a couple of surprises. In this insight, we take a closer look at our expectations for index flows and potential trading ideas

Onewo IPO: The Bull Case

By Arun George

  • Onewo Space-Tech (ONEWO HK), China Vanke (000002 CH)’s property management unit, has begun pre-marketing a US$2.0 billion HKEx IPO.
  • Onewo ranked first in China’s property management services market as measured by revenue from basic property management services, with a market share of 4.28% in 2021.
  • The key elements of the bull case rest on the solid financial health of the parent, strong growth, growth runway from undelivered GFA, share gains, renewal rates and cash generation.

SCBx – Positive Strategy Development

By Daniel Tabbush

  • The decision to not invest in BitKrub, crypto currency exchange, is highly positive
  • Net interest margins are rising, with better loan yields, stable deposit costs
  • Stage 2 loan decline is substantial, positive for future NPL outlook

Central China – Earnings Flash – H1 FY 2022 Results – Lucror Analytics

By Leonard Law, CFA

CCRE’s results were poor, albeit in line with expectations as the company had issued a profit warning in August. The company was significantly impacted by several headwinds specific to Henan (e.g. the floods in H2/21 and COVID-19 lockdowns in H1/22), as well as the nationwide deterioration in homebuyer and investor sentiment. As a result, net debt and leverage worsened by more than expected.

Going forward, we believe that CCRE’s debt repayment prospects remain highly uncertain, given the company’s depleted liquidity and poor operating cash flows (due to the weak sales and very low margins). In addition, we believe the planned convertible bond issuance would help to enhance the company’s liquidity, but is insufficient to cover the large funding gap in FY 2023. Positively, Chairman Wu Po Sum has displayed a strong willingness to honour the company’s commitments. We highlight that the development of synergies with Henan Railway to achieve new business and financing opportunities may be critical for CCRE to continue staving off default.


Derivatives Dominate ETH Markets Ahead of Merge

By Kaiko

  • The perpetual futures market serves as the battleground for institutions, risk-hedgers and speculators alike.
  • In the bull run of 2021, perpetual futures acted as one of the main catalysts for all time highs as new money piled into the market with excessive leverage.
  • Flash forward to September 2022 and we’re seeing this new money return to perpetual futures markets more ferociously than ever, specifically for ETH, with open interest recently breaking all time highs, ahead of one of the biggest idiosyncratic catalysts crypto has seen in some time, the Ethereum Merge. 

Block Inc (formerly Square Inc): The New Square Stand & Other Drivers

By Baptista Research

  • After a steep correction in the past few months, Block is trading sideways but continues to remain a highly volatile script.
  • The company delivered an all-around beat but the sideways trajectory has continued.
  • In the quarter, within Cash App, Block introduced an innovative investing feature named ‘Round Ups’ to make investing accessible and relatable to everyone.

China SCE – Earnings Flash – H1 FY 2022 Results – Lucror Analytics

By Shu Hui Woon

China SCE’s H1/22 results were reasonable, considering the industry weakness. Positively, the company has maintained a good repayment track record. It repaid the USD bonds due in March on a timely basis, and repaid CNY 953 mn that was put back for CNY 1.46 bn puttable bonds in July. This reflects positively on management’s willingness to fulfil obligations, which could increase the company’s likelihood of surviving the property crisis. Moreover, the Yangtze River Delta region accounted for 36% of SCE’s existing land bank, while the West Taiwan Strait Economic Zone and Greater Bay Area accounted for another 30% in total. These regions have growth potential and will likely rebound once operating conditions improve.

Negatively, SCE was not among the companies selected by authorities for the issuance of state-backed guaranteed bonds. Hence, it is unclear if the company can continue to raise financing on its own, without explicit government support. That said, management said it will work to be included in the next batch of developers if possible. The company also intends to dispose of assets to alleviate the liquidity pressure, albeit this might entail execution risk.


CIFI Holdings – Earnings Flash – H1 FY 2022 Results – Lucror Analytics

By Leonard Law, CFA

CIFI Holdings’ H1/22 results were slightly below our expectations. The company reported a moderate increase in net debt, which appears to contradict its deleveraging plans. Moreover, we believe CIFI’s liquidity is tight, as only one-third of its cash on hand is freely available. We note the company has to bear the burden of ensuring property deliveries at its JV projects (particularly if the JV partner is under distress). This may add to CIFI’s cash outflows as it acquire stakes from JV partners. The tight liquidity is also evidenced by the company’s failure to call the perpetual securities in August 2022, as well as the new share placement at a 12% discount.

Positively, CIFI enjoys relatively good access to financing (compared to other private developers), which greatly enhances its near-term debt repayment prospects. In this regard, the company expects to complete the issuance of CNY 1.5 bn in onshore state-guaranteed bonds around mid-September 2022. We expect CIFI to repay its sole maturing bond in the next 12 months (the USD 300 mn CIGIHF 5.5 23 coming due in January 2023).


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Comfortdelgro Corp, Bharat Electronics, Adani Enterprises, China Communications Construction, Sany Heavy Industry, United Airlines Holdings and more

By | Daily Briefs, Industrials

In today’s briefing:

  • STI Index Rebalance: Emperador IN, ComfortDelGro OUT
  • NIFTY NEXT50 Index Rebalance: Significant Impact for an Overlooked Index
  • NIFTY50 Index Rebalance: Adani Enterprises Replaces Shree Cement
  • China Comm Const (1800 HK): Key Takeaways from Post-1H22 Call
  • NIFTY Sep 2022 Rebal: Adani Enterprises and Adani Total Gas Are Top Positives
  • Sany Profit Falls 73.85% as Demand for Construction Gear Dries Up
  • United Airlines: Sustainable Aviation Fuel Update & Other Drivers

STI Index Rebalance: Emperador IN, ComfortDelGro OUT

By Brian Freitas



NIFTY50 Index Rebalance: Adani Enterprises Replaces Shree Cement

By Brian Freitas


China Comm Const (1800 HK): Key Takeaways from Post-1H22 Call

By Osbert Tang, CFA

  • China Communications Construction (1800 HK) should see positive new contract momentum in 2H22. We also expect softening in cost pressure to bring about better margin. 
  • It is actively looking to recycle and realise the value of its assets and good progress are expected in 2H22. Such moves will narrow the currently deeply discounted 0.18x P/B. 
  • With order backlog amounting to 4.6x of annualised 1H22 revenue, earnings prospects are well secured, making its FY22F PER of 2.6x and FY23F of 2.3x very cheap.

NIFTY Sep 2022 Rebal: Adani Enterprises and Adani Total Gas Are Top Positives

By Janaghan Jeyakumar, CFA

  • The September 2022 Rebalance results for the NIFTY 50, 100, and 500 Indices were announced after the close on 1st September 2022.
  • There will be one ADD/DEL for the NIFTY 50 Index and 6 ADDs/DELs for the NIFTY 100 Index, mostly in line with our expectations.
  • In this insight, we take a closer look at our expectations for index flows and potential trading ideas.

Sany Profit Falls 73.85% as Demand for Construction Gear Dries Up

By Caixin Global

  • Sany Heavy Industry, one of China’s largest construction machinery makers, reported a plunge in first-half profit as slower growth and Covid restrictions reduce demand for building equipment.
  • Revenue fell 40.9% to 39.7 billion yuan ($5.76 billion) for the first six months of 2022, the company said Tuesday. Net income plummeted 73.85% to 2.63 billion yuan.
  • Excavators are Sany’s core product. In the first half, the company’s excavator sales declined 35.6% year-on-year to 16.7 billion yuan

United Airlines: Sustainable Aviation Fuel Update & Other Drivers

By Baptista Research

  • United Airlines had a disappointing quarter despite seeing an unprecedented return of customers.
  • In this quarter, Cargo remained strong and premium leisure has been a bright spot as the domestic revenue growth of premium cabins outpaces the economy cabin.
  • We provide the United Airlines stock with a ‘Hold’ rating with a revised target price.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars